Market revenue in 2023 | USD 660.0 million |
Market revenue in 2030 | USD 1,443.0 million |
Growth rate | 11.8% (CAGR from 2023 to 2030) |
Largest segment | Type a |
Fastest growing segment | Type A |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Type A, Type B |
Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.45% in 2023. Horizon Databook has segmented the China botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the BoNT injectable market in China can be attributed to increasing demand for antiaging and antipollution procedures. Nearly 23% of the population in China is geriatric, which is expected to boost the adoption of noninvasive esthetic treatments, leading to market growth.
The buying power of China’s growing middle-class population is increasing, and the local population is more inclined to buy quality products, making the country the world’s second-largest esthetic market after the U.S Increasing demand for noninvasive esthetic treatment by men is also anticipated to boost market growth in China.
The demand for Botox has increased in the past few years owing to various factors such as reduced adverse effects and faster recovery post these procedures. However, an increase in market demand has also led to a rise in the number of beauty salons using fake and unlicensed supplies to leverage the popularity of these procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the China botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into China botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account